← TrialMatch
HomeTrials

Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise T

Patients living with HIV (PLWHIV) have compromised muscle metaboreflex, which can cause exercise intolerance. This randomized controlled clinical trial will verify the effects of regular exercise on autonomic and hemodynamic responses to muscle ergoreflex activation in these patients. PLWHIV without regular physical ex

Condition(s)HIV Infections
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryPatients living with HIV (PLWHIV) have compromised muscle metaboreflex, which can cause exercise intolerance. This randomized controlled clinical trial will verify the effects of regular exercise on autonomic and hemodynamic responses to muscle ergoreflex activation in these patients. PLWHIV without regular physical exercise will be randomly assigned into an exercise training or a control group. The exercise training group will undergo regular physical exercise during 12 weeks (60-min session performed 3 times/wk with moderate intensity), while the control group will keep inactive. Another group consisted of inactive HIV-uninfected group will be included. The primary endpoints will be blood pressure and autonomic markers in response to the Stroop Color-Word Test and the activation of muscl
Who can participateInclusion Criteria for people living with HIV: * diagnosis of HIv infection for at least 5 years; * use of combined antiretroviral therapy for at least 3 years; * asymptomatic and free from opportunistic diseases at enrollment. Exclusion Criteria: * regular physical exercise; * malnutrition; * presence of coronary artery disease, ischemic diseases, pulmonary disease, diabetes, Chagas disease, tuberculosis, heart failure, hypertension; * using pacemakers and/or antidepressant, antiarrhythmic or antihypertensive medication, especially beta-blockers.
Ages30 Years to 50 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorInstituto Nacional de Cardiologia de Laranjeiras
LocationsRio de Janeiro, Rio de Janeiro, Brazil
Start date2024-08-01
NCT IDNCT04512456
Official listinghttps://clinicaltrials.gov/study/NCT04512456

🔍 Search all trials →